NSETrading Window28 Sept 2026 · 28 Sept 2026, 11:27 am
Trading Window
Sai Life Sciences Limited · SAILIFE
✦ AI Summary
Sai Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the unaudited financial results for the second quarter and half year ending on 30th September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sai Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
SAILIFE_28092026112739_Stx_Intimation_TWC_Signed.pdf
View document text
28th September 2026
To To
The Listing Department, The Corporate Relations Department,
National Stock Exchange of India Limited BSE Limited
NSE Symbol: SAILIFE BSE Scrip code: 544306
Dear Sir/Madam,
Ref: SEBI (Prohibition of Insider Trading) Regulations, 2015 (“SEBI PIT
Regulations”).
Sub: Closure of Trading Window for declaration of Unaudited Financial Results for
the second quarter and half year ending on 30th September 2026.
Pursuant to the provisions of SEBI PIT Regulations read with Code of Conduct For
Regulating, Monitoring And Reporting of Trading by Designated Persons and Their
Immediate Relatives (“Code”), the Trading Window for dealing in securities of the
Company for all the Designated Persons and their immediate relatives shall remain
closed with effect from Thursday, 01st October 2026 till the end of 48 hours after the
announcement of the unaudited financial results of the Company for the second
quarter and half year ending on 30th September 2026.
Accordingly, all the Designated Persons and their immediate relatives including
insiders as per the said code, are being intimated not to enter any transaction involving
dealing/trading in shares of the Company during the aforesaid period.
Further, the date of Board Meeting to consider and approve the unaudited financial
results of the Company for the second quarter and half year ending on 30th September
2026, shall be intimated in due course.
Kindly take the above information on your record.
Thanking you.
Yours sincerely,
For Sai Life Sciences Limited
Runa Karan
Company Secretary & Compliance Officer
Membership No. A13721
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office Contact us
T: +91 40 6815 6000,
# L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally
F: +91 40 6815 6199
#133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri
E: info@sailife.com
Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India.
W: www.sailife.com
Telangana, India.